Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Till Bussemer in Pharmaceutical Chemistry
Introduction: Till Bussemer, an accomplished inventor based in Frankfurt am Main, Germany, has made significant strides in the field of pharmaceutical chemistry. With a focus on developing stable formulations for advanced medications, his work holds great promise for improving patient care.
Latest Patents: Bussemer is credited with one notable patent, titled "Otamixaban formulations with improved stability." This invention pertains to a pharmaceutical composition that includes methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt and a pharmaceutically acceptable acidic reacting compound. Furthermore, it encompasses an aqueous solution or dispersion of the composition, along with a process for its preparation. The methods detailed in this patent are aimed at treating individuals with conditions that can be mitigated by an inhibitor of Factor Xa.
Career Highlights: Till Bussemer is currently employed at Sanofi, a global leader in the pharmaceutical industry. His work directly contributes to the innovative spirit of the company, focusing on creating solutions that improve the quality of healthcare.
Collaborations: Throughout his career, Bussemer has collaborated with esteemed colleagues such as Walter Kamm and Doris Andert. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the potential of their collective inventions.
Conclusion: Till Bussemer stands out as a remarkable inventor whose contributions to pharmaceutical science demonstrate the importance of innovation in medicine. His patent on improved otamixaban formulations showcases his dedication to enhancing therapeutic options, solidifying his position as a valuable asset to both his company and the wider medical community.